Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis

Respiration

Volumn 80, Issue 4, 2010, Pages 275-284

  Eum, Seok Yong ^a   Lee, Ye Jin ^a   Min, Jin Hong ^b   Kwak, Hyun Kyung ^a   Hong, Min Sun ^a   Kong, Ji Hye ^a   Hwang, Soo Hee ^b   Park, Seung Kyu ^b   Leblanc, Jason J ^d   Via, Laura E ^d   Barry III, Clifton E ^d   Cho, Sang Nae ^c  

^a International Tuberculosis Research Center   (South Korea)

^b National Masan Hospital   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Chemotherapy; Interferon ; Interleukin 10; Interleukin 12; Multidrug resistant tuberculosis; Mycobacterial clearance; Tuberculosis; Tumor necrosis factor

Indexed keywords

ANTIGEN; BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SPUTUM ANALYSIS; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77957001852     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000283687     Document Type: Article

References (30)

1. Blasi F, Tarsia P, Aliberti S: Strategic targets of essential host-pathogen interactions. Respiration 2005; 72: 9-25.
2. Flynn JL, Chan J: Immunology of tuberculosis. Ann Rev Immunol 2001; 19: 93-129.
3. Vergne I, Chua J, Deretic V: Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca 2+ /calmodulin-PI3K hVPS34 cascade. J Exp Med 2003; 198: 653-659.
4. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF: T-cell cytokine responses in human infection with Mycobacterium tuberculosis . Infect Immun 1995; 63: 3231-3234.
5. Eum SY, Jeon BY, Min JH, Kim SC, Cho SA, Park SK, Cho SN: Tumor necrosis factoralpha and interleukin-10 in whole blood is associated with disease progression in pulmonary multidrug-resistant tuberculosis patients. Respiration 2008; 76: 331-337.
6. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA: Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
7. Heifets LB: Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. Boca Raton, CRC, 1991, pp 89-121.
8. Hussain R, Talat N, Shahid F, Dawood G: Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development. Clin Vaccine Immunol 2007; 14: 1578-1586.
9. World Health Organization, International Union against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association: Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001; 5: 213-215.
10. Torres M, Herrera T, Villareal H, Rich EA, Sada E: Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis . Infect Immun 1998; 66: 176-180.
11. Lee JS, Song CH, Kim CH, Kong SJ, Shon MH, Kim HJ, Park JK, Paik TH, Jo EK: Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol 2002; 128: 516-524.
12. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, Peters P, Ellner JJ: Depressed T-cell interferon-responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999; 180: 2069-2073.
13. Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S: Increase in tumor necrosis factor alpha-and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects with Mycobacterium tuberculosis . Infect Immun 1991; 59: 3021-3025.
14. Kupeli E, Karnak D, Beder S, Kayacan O, Tutkak H: Diagnostic accuracy of cytokine levels (TNF-, IL-2 and IFN-) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients. Respiration 2008; 75: 73-78.
15. Hussain R, Kaleem A, Shahid F, Dojki M, Jamil B, Mehmood H, Dawood G, Dockrell HM: Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 2002; 264: 95-108.
16. Sanchez FO, Rodriguez JI, Agudelo G, Garcia LF: Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 1994; 62: 5673-5678.
17. Inokuchi N, Sugahara K, Soda H, Usui T, Hirakata Y, Fukushima K, Yamada Y, Kohno S, Kamihira S: Relationship between wholeblood interferon-gamma production and extent of radiographic disease in patients with pulmonary tuberculosis. Diagn Microbiol Infect Dis 2003; 46: 109-114.
18. Johnson BJ, McMurray DN: Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis -infected monocytes. Infect Immun 1994; 62: 1444-1450.
19. Surcel HM, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G, Ivanyi J: Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994; 81: 171-176.
20. Ellner JJ, Hirsch CS, Whalen CC: Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis 2000; 30:S279-S282.
21. Sodhi A, Gong J, Silva C, Qian D, Barnes PF: Clinical correlates of interferon-production in patients with tuberculosis. Clin Infect Dis 1997; 25: 617-620.
22. Cooper AM, Magram J, Ferrante J, Orme IM: Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis . J Exp Med 1997; 186: 39-45.
23. Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H, Nelwan RHH, Marzuki S, van der Meer JWM, van Crevel R, van de Vosse E, Ottenhoff THM: Dynamic changes in pro-and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007; 75: 820-829.
24. Lee HW, Lee HS, Kim DK, Ko DS, Han SK, Shim YS, Yim JJ: Lack of association between interleukin-12 receptor-1 polymorphisms and tuberculosis in Koreans. Respiration 2005; 72: 365-368.
25. Gong JH, Zhang M, Modlin RL, Linsley PS, Iyer D, Lin Y, Barnes PF: Interleukin-10 downregulates Mycobacterium tuberculosis -induced Th1 responses and CTLA-4 expression. Infect Immun 1996; 64: 913-918.
26. Appelberg R, Castro AG, Pedrosa J, Silva RA, Orme IM, Minoprio P: Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun 1994; 62: 3962-3971.
27. Lee JS, Song CH, Lim JH, Kim HJ, Park JK, Paik TH, Kim CH, Kong SJ, Shon MH, Jung SS, Jo EK: The production of tumor necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis . Clin Exp Immunol 2003; 132: 443-449.
28. Sharma S, Sharma M, Roy S, Kumar P, Bose M: Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumor necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis. Immunol Cell Biol 2004; 82: 377-382.
29. Ribeiro-Rodrigues R, Resende Co T, Johnson JL, Ribeiro F, Palaci M, Sa RT, Maciel EL, Pereira Lima FE, Dettoni V, Toossi Z, Boom WH, Dietze R, Ellner JJ, Hirsch CS: Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol 2002; 9: 818-823.
30. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE 3rd: A glycolipid of hypervurulent tuberculosis strains that inhibits the innate immune response. 2004; 431: 84-87.